-
Download Library
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
Download Library
Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.
Title Date Type Size 2008 Annual Report 
1.6 MB 2009 Proxy Statement 2009
353.9 KB 2009 Proxy Card Apr 13, 2009
29.0 KB Enzon_2009_PhRMA_Code_CEO_CCO_certification.pdf
30.8 KB 2007 Annual Report 2007
1.3 MB Governance and Nominating Committee 
N/A Finance and Audit Committee
N/A Compensation Committee
N/A Code of Conduct and Corporate Values
N/A California Compliance Declaration
N/A Showing 1-10 of 15 Page: 1 2 Next 10
| (ENZN) NASDAQ | |
| Last Trade | 9.850 |
| Change(%) |
0.04
|
| Volume | 651,900 |
| Mar 9, 2010 3:59 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
-
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.
-
02-17-2010
Fourth Quarter Earnings Call
-
11-03-2009
Third Quarter Earnings Call
-
08-05-2009
2009 BMO Capital Markets 9th Annual Focus on Healthcare Conference
-
08-04-2009
Second Quarter Earnings Call
-
Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
-
03-08-2010
Enzon's Debt is Reduced by $116 Million
--Debt converted into an additional 13.5 million shares--
-
02-24-2010
Enzon Opens Pediatric Study of PEG-SN38
-
02-22-2010
Enzon Board of Directors Appoints Executive Committee
Jeffrey Buchalter Steps Down as CEO of Enzon
-
02-17-2010
Enzon Reports 2009 Results
--Sale of Specialty Pharmaceutical Business brings over $300 million in value--